Skip Navigation
Print This Page
Share this page: More

Namandje Bumpus, Ph.D.

Co-Investigator, JHU NIMH Therapeutics Core
Assistant Professor of Clinical Pharmacology, Johns Hopkins University

Namandje Bumpus, PhD

Namandjé N. Bumpus received a PhD in pharmacology from the University of Michigan and performed thesis research in the laboratory of Dr. Paul F. Hollenberg where she investigated the effect of a naturally occurring cytochrome P450 (CYP) 2B6 mutation on the ability of the enzyme to become inactivated by known inactivators of the wild-type enzyme.

As a postdoctoral fellow with Dr. Eric F. Johnson at The Scripps Research Institute, Namandjé studied the regulation of cyp4a and cyp4f genes in mice. Namandjé is currently an Assistant Professor in the Division on Clinical Pharmacology and her research program is focused on defining the role of drug metabolism and reactive metabolite formation in the toxicities associated with the use of non-nucleoside reverse transcriptase inhibitors to treat HIV-1.

Learn more about the Therapeutics Core.


The Johns Hopkins NIMH Center newsletter

Clinical Perspectives

HANSA 2011 Presentations

View a presentation by Dr Justin McArthur entitled "NeuroAIDS Research Needs in the Era of HAART."
Learn more.

Out-of-State and International Patients - Find Out More


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer